Operating Margin

After a strategic pivot reverses a year of decline, Allurion's preliminary results show new growth. All eyes are now on the FDA for its 'procedureless' gastric balloon.

The insurance giant landed a major credit facility, calming investor nerves and doubling down on its fast-growing pharmacy and healthcare services arm.

Utz Brands posted strong 2025 profit growth and market share gains, overcoming retail inventory issues caused by economic headwinds like SNAP delays.

IDEXX prepares to release its 2025 results, with all eyes on whether its high-tech product launches can sustain momentum in a complex pet care market.

Pomeroy launches an immersive Client Experience Center in Manhattan, using hands-on tech to transform sales into a collaborative innovation process.

CVS Health is set to reveal its 2025 results. Will its integrated strategy pay off amid rising costs, PBM scrutiny, and a key Aetna turnaround?

Prescryptive and Ilant Health unveil a direct-to-employer model for obesity drugs, promising transparent pricing and better clinical outcomes for employers.

ChipMOS reports stunning 20.8% Q4 growth, highlighting a memory chip frenzy fueled by AI and datacenters. Is this the start of a new tech supercycle?

Swiss lab automation giant Tecan shows signs of a turnaround with robust H2 2025 orders, betting on AI to navigate a recovering life sciences market.

As Copa Holdings prepares its Q4 2025 results, investors and analysts will scrutinize if the airline can sustain its stellar performance and margins.

Record AI mega-deals redefine healthcare innovation, yet a broader market contraction creates a new divide for startups and traditional medical sectors.

The LA Rams and energy firm CRC mark one year of a partnership to offset team emissions, but does this innovative, local-first model truly change the game?

After 30 years, CEO Jim Foster will retire, passing the torch to COO Birgit Girshick in a move that signals continuity and a new era of governance.

A major customer delay impacts Ceragon's Q4 revenue, but the company projects significant growth in 2026, banking on a strong backlog and new markets.

CMS withdraws a controversial rule, ensuring patient access to advanced wound care, but a new payment model still looms over the MedTech industry.

Jasmine Alarcon’s promotion to oversee Southwest Marines housing comes as the privatized military housing sector faces intense pressure for reform.

Employer health plans are using 'alternative funding' to cut costs, but critics warn these schemes force patients to use risky, non-FDA approved drugs.

Peachtree Group's new division closes nearly $30M in its first quarter, capitalizing on a growing credit gap in middle-market equipment finance.

A new global study shows consumers embrace AI for product research but don't trust it for purchases, revealing a 'Confidence Economy' ruled by transparency.

A new tri-specific antibody, IM1240, safely hits cancer cells at massive doses in preclinical studies, potentially solving a key toxicity problem in immunotherapy.